Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study (NCT05460676) | Clinical Trial Compass
CompletedNot Applicable
Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study
United States43 participantsStarted 2023-08-15
Plain-language summary
The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.
Who can participate
Age range21 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 21-75 years old
* Smoke ≥5 cigarettes per day and express interest in quitting smoking in next 30 days
* Mild to moderate distress defined as K10 scores 10-35
* Self reported previous diagnosis of cancer
* Psychotropic medication stable for ≥1 month prior to enrollment and throughout the trial, at the discretion of the study physician
* Access to a reliable internet connection, able to use mobile device, and complete online questionnaires, competent in instrumental activities of daily living
* Able to read and understand informed consent and questionnaires in English (WRAT-4 score≥85)
Exclusion Criteria:
* Inability to effectively use study-provided supplies
* Chronic non-compliance with study procedures
* Changes in health information over the course of enrollment in the study which place the participant at higher risk for an adverse event (as determined by Study Physician or Principal Investigator; e.g. medication changes, invasive procedures)
* Temporary or permanent obstructions to making contact between the electrodes and the scalp (e.g. wig that the participant is not willing to remove)
* History of traumatic brain injury, brain metastases, seizure disorder, recent (\<5 years) seizure history, or a neurodegenerative disease or neurocognitive disorder associated with significant impairment (e.g. Parkinson's, Dementia)
* Current severe major depressive disorder, lifetime history of psychotic disorders or bipolar disorder type I, or current suicida…
What they're measuring
1
Feasibility and Tolerability Questionnaire (FTQ) score